Vivos Therapeutics (VVOS) Accounts Payables (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Accounts Payables of $2.0 million for Q1 2026, up 65.51% year-over-year from $1.2 million in Q1 2025, and up 18.88% quarter-over-quarter from $1.7 million in Q4 2025.
Vivos Therapeutics (VVOS) Accounts Payables (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Accounts Payables for 8 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 65.51% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 65.51% YoY), while the FY2025 annual figure was $1.7 million, up 52.91% from the prior year.
- Accounts Payables grew to $2.0 million in Q1 2026 per VVOS's latest filing, from $1.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $2.5 million in Q1 2024 and bottomed at $644000.0 in Q3 2022.
- Historically, Accounts Payables has averaged $1.5 million across 5 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2023 — Accounts Payables surged 137.27% — and 2025, when it sank 51.74%.
- Vivos Therapeutics' Accounts Payables stood at $1.4 million in 2022, then soared by 52.02% to $2.1 million in 2023, then plunged by 48.81% to $1.1 million in 2024, then soared by 52.91% to $1.7 million in 2025, then advanced by 18.88% to $2.0 million in 2026.
- Business Quant data shows VVOS's Accounts Payables at $2.0 million in Q1 2026, $1.7 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 644,000.00 |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 877,000.00 |
| Dec 31, 2021 | 920,000.00 |
| Sep 30, 2021 | 700,197.00 |
| Jun 30, 2021 | 1.30 Mn |